SciELO - Scientific Electronic Library Online

 
vol.17 número5Diabetes y malformaciones congénitas. Cienfuegos, 2005-2015Diseño de sistema para controlar una silla de ruedas mediante señales eléctricas cerebrales índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


MediSur

versión On-line ISSN 1727-897X

Resumen

LARA CALDERIN, Gloria et al. Results of the application of Heberprot-P for the treatment of diabetic foot ulcer. Medisur [online]. 2019, vol.17, n.5, pp. 641-649.  Epub 02-Oct-2019. ISSN 1727-897X.

Foundation:

diabetes mellitus is a chronic disease. One of its frequent complications is the diabetic foot. For its treatment Heberprot-P is used.

Objective:

to describe the results of the application of Heberprot-P for the treatment of diabetic foot ulcer.

Methods:

prospective descriptive study conducted in the Diabetic Care Consultation, during the period from April 2009 to April 2016. The sample consisted of the 41 patients with diabetic foot ulcer older than 20 years, to whom the treatment with Heberprot-P. We analyzed: age, associated diseases, years of evolution of the disease, medication dose and healing.

Results:

female patients predominated (56.1%); the age group of 60-69 years (34.2%) and hypertension as an associated disease (48.8%); 43, 9% had an evolution of diabetes of 10-19 years; according to the Wagner classification, group III prevailed with 48.8% and II with 31.7%; 5 to 9 doses of Heberprot-P were applied in 43.5%. 78% achieved complete healing.

Conclusions:

in three quarters of patients with diabetic foot ulcer complete healing was achieved with the application of Heberprot-P therapy.

Palabras clave : diabetic food; treatment outcome; epidermal growth factor; drug therapy; wuond healing.

        · resumen en Español     · texto en Español     · Español ( pdf )